Semaglutide vs Tirzepatide: The Molecules, the Receptors, and the Outcomes

Semaglutide and tirzepatide are the two most talked-about weight-loss and diabetes medications, and they are easy to confuse. They are not the same drug, they do not work the same way, and in head-to-head testing they did not produce identical results. Here is a clear, evidence-based comparison.

Semaglutide vs tirzepatide: mechanism of action

This is the core difference.

• Semaglutide mimics GLP-1, a hormone that increases insulin when blood sugar rises, slows stomach emptying, and reduces appetite signaling in the brain. One receptor, one pathway.
• Tirzepatide mimics two hormones, GLP-1 and GIP. Adding GIP activity appears to enhance the appetite and metabolic effects, which is the leading explanation for the larger weight loss seen with tirzepatide.

So tirzepatide is a dual-receptor agonist and semaglutide is a single-receptor agonist. That mechanistic difference is why the two are not interchangeable and why their results differ.

Difference between semaglutide and tirzepatide at a glance

Figures are averages from the trials each drug was studied in and vary by dose and study.

Is tirzepatide better than semaglutide?

On weight loss specifically, the evidence leans toward tirzepatide. In SURMOUNT-5, the head-to-head trial published in 2025, participants on tirzepatide lost 20.2% of body weight on average versus 13.7% on semaglutide, roughly 47% greater weight loss. That does not make it "better" for everyone. Semaglutide has a longer real-world track record, may be better tolerated by some, and is sometimes more accessible or affordable depending on coverage and supply. "Better" depends on your weight-loss target, side-effect tolerance, cost, and whether you have type 2 diabetes.

Is Wegovy better than tirzepatide?

Wegovy is the weight-loss brand of semaglutide. Comparing Wegovy to tirzepatide (Zepbound) is the same semaglutide-vs-tirzepatide question with brand names attached. In SURMOUNT-5, tirzepatide produced more weight loss on average (20.2% vs 13.7%), but Wegovy remains a proven, FDA-approved option. Tolerability and individual response matter, some people do better on one than the other regardless of the averages.

Side effects: similar profile, different intensity

Both drugs share a gastrointestinal side-effect profile, nausea, vomiting, diarrhea, constipation, and reduced appetite, most common when starting or increasing the dose. These usually ease with slow titration. Because tirzepatide is generally more potent, some people find its effects more pronounced. Starting low and stepping up gradually is the standard way to limit side effects for both.

Which should you choose?

Talk with a licensed clinician, but the general logic is: if maximum average weight loss is the priority and you tolerate it, tirzepatide often comes out ahead; if you value a longer track record or it is more accessible to you, semaglutide is a strong choice. If you want to compare supervised programs for either medication on cost and clinical oversight, FormBlends' provider comparison tool lets you line them up, and our compounded semaglutide page explains how a supervised GLP-1 program is structured.

FAQs

What is the main difference between semaglutide and tirzepatide?

Semaglutide targets one hormone receptor (GLP-1); tirzepatide targets two (GIP and GLP-1), which is linked to its larger average weight loss.

Is tirzepatide stronger than semaglutide?

On average, tirzepatide produced greater weight loss in the head-to-head SURMOUNT-5 trial, but individual results vary.

Are semaglutide and tirzepatide the same?

No. They are different molecules with different mechanisms, made by different companies.

Is Wegovy better than tirzepatide?

Wegovy is semaglutide for weight loss. Tirzepatide showed more average weight loss in trials, but Wegovy is proven and may suit some people better.

Do they have the same side effects?

Both cause mainly gastrointestinal effects. Tirzepatide's can feel more pronounced because it is generally more potent.

Which is better for type 2 diabetes?

Both lower blood sugar effectively; the SURPASS (tirzepatide) and SUSTAIN (semaglutide) programs support each. Your clinician decides based on your profile.

Can I switch from one to the other?

Yes, under clinical supervision, with re-titration. Do not switch on your own.

Are both weekly injections?

Yes, semaglutide and tirzepatide injections are weekly. Rybelsus is a daily oral semaglutide tablet.

Related guides

• What Is the Difference Between Ozempic and Tirzepatide: Active Ingredients, Mechanisms, and Clinical Outcomes Compared
• What's the Difference Between Semaglutide and Tirzepatide? A Complete Side-by-Side Comparison
• What's the Difference Between Semaglutide and Tirzepatide: Mechanism, Efficacy, and Which One Actually Works Better
• What Is the Difference Between Tirzepatide and Semaglutide? The Mechanism, Efficacy, and Clinical Decision Framework
• What's the Difference Between Tirzepatide and Semaglutide: The Mechanism, Efficacy Data, and Which One Works Better
• Tirzepatide vs Semaglutide Dosage Chart: Side-by-Side Escalation Schedules and Clinical Differences

Sources

• Eli Lilly, SURMOUNT-5 head-to-head results (2025): https://investor.lilly.com/news-releases
• NEJM / STEP and SURMOUNT trial publications overview: https://www.nejm.org/
• FDA prescribing information for Wegovy and Zepbound: https://www.accessdata.fda.gov/scripts/cder/daf/